Pharming is a global biotechnology company that develops and commercializes innovative medicines for people living with rare and ultra-rare immune and genetic diseases. The company focuses on rare immunological and genetic conditions such as hereditary angioedema, activated PI3K delta syndrome, and primary mitochondrial disease, combining clinical development, manufacturing, regulatory affairs, and commercialization capabilities.

Pharming is a global biotechnology company that develops and commercializes innovative medicines for people living with rare and ultra-rare immune and genetic diseases. The company focuses on rare immunological and genetic conditions such as hereditary angioedema, activated PI3K delta syndrome, and primary mitochondrial disease, combining clinical development, manufacturing, regulatory affairs, and commercialization capabilities.